Company intelligence / Profile preview

Vine Ventures

Zurich, Switzerland

Ownership: Private
Development stage: Other

Overview

Vine Ventures is an early-stage venture capital firm focused on mental health, wellness, psychedelic therapies, neurotechnology, and longevity. It has invested $20M in 32 early-stage companies and led a $45M SPV for MAPS to support MDMA for PTSD. The firm commits 50% of its profits to mental health philanthropy.

Industry: Investors

Beyond the preview

Go deeper on Vine Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vine Ventures.

Explore the full profile